Stay updated on Batoclimab in Active Thyroid Eye Disease Clinical Trial
Sign up to get notified when there's something new on the Batoclimab in Active Thyroid Eye Disease Clinical Trial page.

Latest updates to the Batoclimab in Active Thyroid Eye Disease Clinical Trial page
- Check2 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.1%
- Check9 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check16 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference1%
- Check23 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.3%
- Check45 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check59 days agoChange DetectedThe page has undergone significant updates, including the removal of detailed study information regarding batoclimab for Thyroid Eye Disease and the introduction of a new revision number. The study is now described as Quadruple-blind.SummaryDifference15%
Stay in the know with updates to Batoclimab in Active Thyroid Eye Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Batoclimab in Active Thyroid Eye Disease Clinical Trial page.